Kontakt | Druckansicht | PDF-Ansicht | Firma weiterempfehlen
PortraitSymphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.
Branchenbereiche